Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAQUINAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where SAQUINAVIR was used for Maternal exposure timing unspecified.

Most Reported Side Effects for SAQUINAVIR

Side Effect Reports % Deaths Hosp.
Lipodystrophy acquired 186 23.5% 0 0
Eyelid ptosis 169 21.3% 0 0
Mitochondrial toxicity 165 20.8% 0 1
Diplopia 161 20.3% 0 0
Foetal exposure during pregnancy 105 13.3% 9 27
Dysphagia 103 13.0% 5 5
Viral mutation identified 82 10.4% 0 2
Drug resistance 77 9.7% 5 10
Progressive external ophthalmoplegia 74 9.3% 0 0
Pathogen resistance 67 8.5% 0 2
Ophthalmoplegia 66 8.3% 0 0
Virologic failure 66 8.3% 0 15
Blood lactic acid increased 60 7.6% 1 10
Treatment failure 51 6.4% 1 0
Anaemia 41 5.2% 2 25

Other Indications for SAQUINAVIR

Hiv infection (526) Product used for unknown indication (110) Antiretroviral therapy (62) Acquired immunodeficiency syndrome (14) Hiv-2 infection (10) Hepatitis c (8) Antiviral treatment (7) Chronic hepatitis c (7) Hiv test positive (7) Hiv infection cdc category c (6)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

SAQUINAVIR Full Profile All Maternal exposure timing unspecified Drugs SAQUINAVIR Demographics SAQUINAVIR Timeline